Tony's Diary Package — page 1103

Bivalent BA.5 Booster Neutralizing Antibody Lab Assessments Suthar 'Shi Pfizer Ho -Barouch "Barouch Bivalent vs. BA.5 Compared to Original 4-fold improved 3-fold improved 4-fold improved Pseudovirus Minimal difference Pseudovirus 1.3-fold increase Pseudovirus No difference LA Times: SINESS COLUMNIST Usa WHO label! Lintage # = US Class Total «= SS %4P I Omicren BAS VOC 32% M247 BO.1,1 YOO 168% 168.7-224% BO. 1 WOOD TRS TILE er BA 4 VOU 985% 6.6-10.5% BF? YOO 0% Fai BAS 2.6 WOO 31% 253% BA 2.75 VOD 20% 128% BA P52 VO> 1.0% O0.8-71.7% BAL 4 VOD OF% O247% BA.1,1 VOD O0% O4h0% B.1.1.429 VOC OFf% O0o00% BA? .12.1 VOC O="F% O000% BAS VOC O0% Oe00% Deita 8.16172 VBM OFf% O0-00% Cther 'thane o.1% 0.040, 1% Bivalent vs. BO.1.1 Compared to Original ~10-fold increased (vs 1 booster) Low, but 3-fold GMT Not assessed Not assessed Not assessed Modest ~1.2-fold increase Great put down of the HELP Report in LA Times: Column: ProPublica and Vanity Fair are pushing the COVID lab-leak theory, but their exposé is a train wreck BY MICHAEL HILTZIKBUSINESS COLUMNIST NOV. 1, 2022 1:15 PM P BQ.1 and BQ.1.1 continues to overcome BA4/5: